On 14 July 2025 it was announced that Victoria will deliver a vaccination program to protect older adults from respiratory syncytial virus (RSV). The RSV vaccine Arexvy will be free for residents aged over 60 years in public and Aboriginal community-controlled aged care services.
RSV is a virus that causes upper and lower respiratory tract infections. Children under 1 year of age, those with underlying medical conditions, the older population and immunocompromised prople are more likely to experience serious disease causing hospitalisation.
RSV vaccines are currently recommended but not widely funded for all adults over 75 years, Aboriginal and Torres Strait Islander adults aged 60 to 74 years, and adults with specified medical conditions aged 60 to 74 years (Arexvy or Abrysvo).
RSV vaccination is recommended and funded for pregnant people from 28 weeks’ gestation (Abrysvo only).
Read more about the new program here
MVEC: Respiratory syncytial virus (RSV)
MVEC: Vaccine administration error alert: Incorrect RSV prevention product